Interventional Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering (CT Scanners, X-Ray Systems, MRI Systems, Ultrasound Imaging Systems, Others), By Application (Cardiology, Neurology, Musculoskeletal, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 26.01 Billion
CAGR (2026-2031)	5.44%
Fastest Growing Segment	Cardiology
Largest Market	North America
Market Size (2031)	USD 35.74 Billion

Market Overview

The Global Interventional Imaging Market will grow from USD 26.01 Billion in 2025 to USD 35.74 Billion by 2031 at a 5.44% CAGR. Interventional imaging encompasses a range of medical technologies, including X-ray fluoroscopy, computed tomography, and ultrasound, utilized to provide real-time visualization for guiding minimally invasive surgical procedures. The global market is primarily supported by the rising prevalence of chronic conditions such as cardiovascular diseases and cancer, which necessitate precise intraoperative guidance for effective treatment. Furthermore, the industry is driven by a fundamental shift in healthcare toward minimally invasive interventions, as these techniques significantly reduce hospital stay durations and minimize patient recovery times compared to traditional open surgeries.

A significant challenge impeding market expansion is the critical shortage of skilled interventional radiologists and technicians required to operate these complex systems and interpret the resulting data. According to the American College of Radiology, in 2025, approximately 67% of radiologists reported that their practices were currently understaffed. This substantial workforce gap limits the operational capacity of healthcare facilities to handle increasing procedural volumes and restricts the broader adoption of advanced interventional solutions in both developed and emerging markets.

Key Market Drivers

The rising prevalence of chronic and cardiovascular diseases serves as the foremost driver propelling the Global Interventional Imaging Market. As the global burden of complex conditions intensifies, healthcare providers are increasingly relying on image-guided therapies to perform precise, minimally invasive treatments that improve patient outcomes. This escalating demand is substantiated by recent epidemiological projections highlighting the critical need for interventional oncology and cardiology services. According to the American Cancer Society, January 2025, in the 'Cancer Facts & Figures 2025', researchers project that 2,041,910 new cancer cases will occur in the United States in 2025. Consequently, hospitals are aggressively expanding their interventional capabilities to manage these growing procedural volumes, directly boosting the procurement of advanced fluoroscopy and CT systems.

Technological innovations, specifically the integration of artificial intelligence and robotic-assisted interventions, act as the second critical force stimulating market development. Manufacturers are rapidly deploying AI algorithms to automate complex workflows, reduce radiation exposure, and enhance real-time image clarity during delicate surgeries. This trend is exemplified by significant regulatory milestones that validate the clinical utility of these next-generation systems. According to GE HealthCare, July 2025, in the 'GE HealthCare drives growth with investment in AI-enabled medical devices' press release, the company reported it had secured 100 FDA authorizations for AI-enabled medical devices to date. This technological evolution translates into substantial economic activity within the sector. According to Boston Scientific, February 2025, in the 'Q4 and Full Year 2024 Financial Results', the company announced that its full-year 2024 net sales reached $16.7 billion, underscoring the lucrative nature of the interventional medicine landscape.

Download Free Sample Report

Key Market Challenges

The critical shortage of skilled interventional radiologists and technicians functions as a primary restraint on the global interventional imaging market. These advanced systems require highly specialized personnel to navigate complex intraoperative procedures and interpret real-time data accurately. When healthcare facilities face a deficit of qualified operators, the utility of such capital-intensive equipment is severely compromised. This labor gap forces hospitals to restrict the volume of minimally invasive procedures they can offer, effectively creating a ceiling on operational capacity. Consequently, the inability to staff these units discourages healthcare providers from procuring additional imaging systems, directly dampening market demand.

This workforce scarcity has measurable repercussions on the adoption rates of new interventional technologies. Without a sufficient pipeline of trained professionals, the return on investment for upgrading or expanding imaging departments becomes difficult to justify. According to the Royal College of Radiologists, in 2024, the workforce shortfall for clinical radiologists in the United Kingdom stood at 29%. Such significant staffing voids limit the ability of medical centers to manage patient throughput, thereby stalling the revenue growth necessary to reinvest in the market's latest imaging innovations.

Key Market Trends

The migration of interventional procedures to Ambulatory Surgical Centers (ASCs) represents a fundamental structural shift in the market, distinct from hospital-based capacity expansion. Payers and healthcare providers are aggressively routing peripheral vascular, pain management, and basic interventional radiology cases to these outpatient settings to capitalize on operational efficiencies and significantly reduced overhead costs. This transition is becoming a financial imperative for large health systems, which are acquiring independent centers to capture high-margin outpatient revenue streams while reserving main hospital facilities for critical care. This accelerating momentum is evident in the recent financial performance of major operators in this space. According to Tenet Healthcare, October 2025, in the 'Q3 2025 Earnings' report, the company's Ambulatory Care segment saw net operating revenues jump 11.9% to $1.275 billion, substantially outperforming traditional hospital operations and validating the sector's rapid expansion.

Simultaneously, leading medical centers are prioritizing the adoption of Hybrid Operating Room configurations to manage increasing procedural complexity. Unlike standard catheterization labs, these advanced suites merge the sterility of a traditional surgical theater with high-end fixed imaging systems, allowing multidisciplinary teams to perform intricate vascular and structural heart repairs without the need for patient transport. This consolidation of capabilities is essential for treating higher-acuity patients, as it enables immediate conversion from minimally invasive techniques to open surgery if intraoperative complications arise. The sustained investment in these capital-intensive environments continues to drive sales of specialized interventional hardware. According to Siemens Healthineers, November 2025, in the 'Q4 Fiscal Year 2025' press release, the Advanced Therapies segment recorded comparable revenue growth of 3.8%, largely driven by the demand for sophisticated angiography and surgery-supporting systems required for these hybrid environments.

Segmental Insights

The Cardiology segment is projected to witness the fastest growth in the Global Interventional Imaging Market due to the escalating incidence of cardiovascular disorders globally. This trend is reinforced by a distinct clinical preference for minimally invasive interventions, such as angioplasty, which demand continuous visual guidance. Regulatory clearances from entities like the U.S. FDA for new interventional angiography systems further facilitate this expansion by ensuring device safety. Consequently, hospitals are investing in catheterization laboratories to manage the high volume of cardiac procedures, thereby propelling the demand for imaging modalities dedicated to cardiology.

Regional Insights

North America maintains a dominant position in the global interventional imaging market, driven by a well-established healthcare infrastructure and the rising preference for minimally invasive surgical procedures. The region experiences a high incidence of chronic lifestyle disorders, necessitating frequent image-guided treatments. Market stability is further supported by favorable reimbursement frameworks from the Centers for Medicare & Medicaid Services, which facilitate hospital investments in diagnostic equipment. Additionally, the U.S. Food and Drug Administration actively regulates and approves medical devices, ensuring the steady availability of tools that strengthen regional market performance.

Recent Developments

• In March 2024, Siemens Healthineers received clearance from the U.S. Food and Drug Administration for the CIARTIC Move, a self-driving mobile C-arm system. This innovative technology was developed to address the challenges of staff shortages and overloaded surgical teams by automating imaging workflows in the operating room. The system featured a motorized chassis that allowed for precise, automated positioning, reducing the physical burden on healthcare professionals and potentially accelerating procedural times. This development represented a meaningful step forward in the integration of robotics and advanced imaging within the interventional environment.
• In March 2024, GE HealthCare showcased its latest innovations in interventional radiology at the Society of Interventional Radiology Annual Scientific Meeting. A key highlight was the introduction of Embo ASSIST AI, a new software application integrated into the Allia IGS platform. This artificial intelligence-based tool was designed to automatically segment vascular structures, thereby facilitating the planning of embolization procedures. By helping clinicians visualize and anticipate injection destinations, the technology aimed to enhance precision and workflow efficiency during complex interventional treatments for various vascular diseases and health conditions.
• In February 2024, Royal Philips announced a significant advancement in the Global Interventional Imaging Market with the launch of the Azurion neuro biplane system. This new image-guided therapy platform was designed to streamline neurovascular procedures, such as the treatment of stroke and brain aneurysms. The system featured enhanced 2D and 3D imaging capabilities, offering improved positioning flexibility for X-ray detectors. By enabling clearer visualization and more efficient workflows, the technology aimed to assist medical teams in making faster decisions and treating patients more effectively, ultimately contributing to better clinical outcomes and reduced cost of care.
• In February 2024, Ziehm Imaging presented an expanded product line for its mobile C-arm portfolio at the European Congress of Radiology. The company highlighted the Ziehm Solo FD, a compact system designed for versatile clinical applications, now featuring enhanced configurations to suit different procedural requirements. This development underscored the company's focus on providing high-quality imaging solutions with a small footprint, catering to the needs of diverse medical settings such as cardiology, orthopedics, and vascular surgery. The expansion aimed to improve intraoperative imaging capabilities while maintaining flexibility and ease of maneuverability for surgical teams.

Key Market Players

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation

By Offering	By Application	By Region
CT Scanners X-Ray Systems MRI Systems Ultrasound Imaging Systems Others	Cardiology Neurology Musculoskeletal Oncology Urology Gastroenterology Obstetrics Gynecology Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Interventional Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Interventional Imaging Market, By Offering:

• CT Scanners
• X-Ray Systems
• MRI Systems
• Ultrasound Imaging Systems
• Others

• Interventional Imaging Market, By Application:

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynecology
• Others

• Interventional Imaging Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE